ARDELYX, INC. cotiza a 3.21 USD y tiene una capitalización bursátil de $829M. En los últimos 12 meses ha facturado $451M con un margen de flujo de caja libre del -10.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorptio…
| Periodo | 2026-10 | 2026-08 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.07 | $-0.15 | — |
| Estimado | $-0.02 | $-0.05 | $-0.14 | $0.01 |
| Sorpresa | — | -40.0% | -7.1% | — |
| Métrica | ARDX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 90.3% | 57.0% | +33.3% |
| Operating Margin | -10.1% | -38.6% | +28.6% |
| Net Margin | -15.1% | -33.6% | +18.4% |
| FCF Margin | -10.8% | -13.9% | +3.1% |
| ROE | -36.9% | -40.4% | +3.5% |
| ROA | -12.3% | -32.0% | +19.7% |
| Current Ratio | 4.31 | 2.84 | +1.47 |
| Debt / Equity | 1.21 | 0.28 | +0.93 |